CHF10073 Inhaled Drug Study

We are evaluating the safety and absorption of the inhaled drug CHF10073 in healthy adults, both alone and with itraconazole. This study aims to understand how the drug behaves in the body.

1-2 yearsSafety phase (I)Internal MedicinePulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
SGS Belgium
SGS-Clinical Research CPU
Wilrijk, Belgium
Sponsor: Chiesi Farmaceutici S.p.A.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.